These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers. Bawazir SA, Gouda MW, El-Sayed YM, Al-Khamis KI, Al-Yamani MJ, Niazy EM, Al-Rashood KA. Int J Clin Pharmacol Ther; 1998 May; 36(5):270-4. PubMed ID: 9629991 [Abstract] [Full Text] [Related]
5. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S. Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [Abstract] [Full Text] [Related]
6. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M. Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [Abstract] [Full Text] [Related]
7. Bioequivalence and pharmacokinetics of chlorpheneramine in healthy human volunteers. Najjar TA, Al-Alsheikh OA, Al-Dhawailie AA, Shereif A. Int J Clin Pharmacol Ther; 1995 Nov; 33(11):619-22. PubMed ID: 8688987 [Abstract] [Full Text] [Related]
9. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA. Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [Abstract] [Full Text] [Related]
10. Bioequivalence of two lamivudine tablet formulations. Santos-Magalhães NS, Pontes A, Cavalcante RM, Costa RM, Rangel FA, Guimarães MI, de Carvalho JN, de Souza SD, de Oliveira HM, Esteves IL, Ramalho MS, Vieira SL, Alves AJ. Arzneimittelforschung; 2001 Oct; 51(4):310-4. PubMed ID: 11367872 [Abstract] [Full Text] [Related]